MeSH term
Frequency | Condition_Probility | Alleles | 38 | 0.0 |
*Carboxylesterase | 95 | 87.0 |
Carboxylic Ester Hydrolases/*genetics | 41 | 77.0 |
Female | 84 | 0.0 |
Humans | 217 | 0.0 |
Isoelectric Focusing | 15 | 2.0 |
Japan | 5 | 0.0 |
Male | 91 | 0.0 |
*Paternity | 7 | 9.0 |
Phenotype | 94 | 1.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 74 | 0.0 |
Blood Group Antigens/*genetics | 18 | 17.0 |
Chi-Square Distribution | 5 | 0.0 |
Cluster Analysis | 3 | 1.0 |
Ethnic Groups/*genetics | 11 | 5.0 |
Gene Frequency | 80 | 1.0 |
Haplotypes | 7 | 0.0 |
*Polymorphism, Genetic | 56 | 1.0 |
English Abstract | 47 | 0.0 |
Heterozygote Detection/*methods | 2 | 3.0 |
Treatment Outcome | 3 | 0.0 |
Comparative Study | 38 | 0.0 |
*Genetic Markers | 27 | 8.0 |
ABO Blood-Group System/*genetics | 4 | 8.0 |
Acid Phosphatase/genetics | 11 | 33.0 |
Erythrocytes/*enzymology | 58 | 11.0 |
Esterases/genetics | 4 | 22.0 |
Lactoylglutathione Lyase/genetics | 11 | 25.0 |
Phosphoglucomutase/genetics | 14 | 30.0 |
Russia | 10 | 10.0 |
*Gene Pool | 7 | 36.0 |
Geography | 2 | 3.0 |
Lactoylglutathione Lyase/*genetics | 3 | 7.0 |
Phosphoglucomutase/*genetics | 5 | 4.0 |
Phosphogluconate Dehydrogenase/*genetics | 3 | 25.0 |
Adult | 41 | 0.0 |
Middle Aged | 14 | 0.0 |
DNA/genetics | 5 | 0.0 |
Ethnic Groups/genetics | 2 | 1.0 |
Enzymes/*genetics | 12 | 28.0 |
Genetic Markers/*genetics | 3 | 2.0 |
*Genetics, Population | 26 | 7.0 |
Italy | 16 | 2.0 |
Polymorphism, Genetic/*genetics | 11 | 0.0 |
*Gene Frequency | 24 | 4.0 |
Multivariate Analysis | 3 | 0.0 |
Variation (Genetics) | 6 | 0.0 |
Asian Continental Ancestry Group | 2 | 0.0 |
Carboxylic Ester Hydrolases/blood/*genetics | 10 | 90.0 |
China | 4 | 0.0 |
Phosphoglucomutase/blood/*genetics | 4 | 19.0 |
Chromosome Mapping | 17 | 0.0 |
Data Interpretation, Statistical | 2 | 0.0 |
Haptoglobins/*genetics | 3 | 7.0 |
*Phenotype | 7 | 2.0 |
Genetic Markers | 37 | 1.0 |
Spain | 10 | 2.0 |
*Variation (Genetics) | 11 | 1.0 |
Animals | 12 | 0.0 |
Evolution | 2 | 0.0 |
Gene Rearrangement | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
African Continental Ancestry Group/*genetics | 3 | 1.0 |
Demography | 2 | 1.0 |
Ecuador | 3 | 27.0 |
Emigration and Immigration | 3 | 6.0 |
Enzymes/genetics | 7 | 21.0 |
Phylogeny | 3 | 0.0 |
Blood Proteins/*genetics | 20 | 12.0 |
Gene Frequency/*genetics | 3 | 2.0 |
Heterozygote Detection | 5 | 0.0 |
Siberia | 4 | 10.0 |
Adenosine Deaminase/genetics | 6 | 27.0 |
Adenylate Kinase/genetics | 9 | 37.0 |
Alanine Transaminase/genetics | 4 | 44.0 |
Carboxylic Ester Hydrolases/genetics | 18 | 60.0 |
Erythrocytes/enzymology | 19 | 4.0 |
Adolescent | 14 | 0.0 |
Aged | 8 | 0.0 |
Genetics, Population | 4 | 1.0 |
HLA Antigens/*genetics | 2 | 0.0 |
Turkey | 2 | 1.0 |
European Continental Ancestry Group | 2 | 0.0 |
Polymorphism, Genetic | 39 | 0.0 |
Anthropometry | 2 | 0.0 |
Child | 19 | 0.0 |
Heterozygote | 10 | 0.0 |
ABO Blood-Group System/genetics | 10 | 23.0 |
Case-Control Studies | 2 | 0.0 |
Complement 3/genetics | 4 | 11.0 |
Isoantigens/genetics | 2 | 10.0 |
Transferrin/genetics | 6 | 12.0 |
Venezuela | 2 | 6.0 |
Genetic Markers/genetics | 5 | 1.0 |
Cattle/*genetics | 2 | 1.0 |
*Chromosome Mapping | 7 | 0.0 |
*Chromosomes, Human, Pair 13 | 8 | 4.0 |
Hamsters | 3 | 0.0 |
Hybrid Cells | 3 | 0.0 |
Mice | 4 | 0.0 |
Sheep/*genetics | 3 | 5.0 |
Base Sequence | 5 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
Bone Marrow Transplantation | 2 | 0.0 |
Carboxylic Ester Hydrolases/analysis/*genetics | 3 | 100.0 |
DNA/analysis | 2 | 0.0 |
*Forensic Medicine | 2 | 4.0 |
Acid Phosphatase/blood/genetics | 3 | 42.0 |
Adenosine Deaminase/blood/genetics | 2 | 50.0 |
Carboxylic Ester Hydrolases/blood/genetics | 4 | 80.0 |
Phosphogluconate Dehydrogenase/blood/genetics | 2 | 40.0 |
Benin | 2 | 33.0 |
Carbonic Anhydrases/genetics | 2 | 22.0 |
Child, Preschool | 5 | 0.0 |
DNA/analysis/genetics | 2 | 1.0 |
Glucosephosphate Dehydrogenase/genetics | 2 | 2.0 |
Infant | 5 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Marriage | 2 | 8.0 |
Pregnancy | 6 | 0.0 |
Carboxylic Ester Hydrolases/*analysis/genetics | 3 | 100.0 |
Isoelectric Focusing/*methods | 4 | 10.0 |
Time Factors | 3 | 0.0 |
Blood Group Antigens/genetics | 5 | 8.0 |
European Continental Ancestry Group/*genetics | 4 | 1.0 |
Europe | 2 | 0.0 |
Blood Proteins/genetics | 11 | 19.0 |
Blood Protein Electrophoresis | 3 | 2.0 |
Greece/ethnology | 2 | 10.0 |
Isoenzymes/genetics | 9 | 2.0 |
*Blood Stains | 6 | 17.0 |
Hemolysis | 2 | 0.0 |
Isoenzymes/*analysis/genetics | 2 | 25.0 |
Substrate Specificity | 2 | 0.0 |
Temperature | 2 | 0.0 |
Haptoglobins/genetics | 7 | 14.0 |
India | 10 | 3.0 |
Lactoylglutathione Lyase/blood/genetics | 3 | 75.0 |
Pedigree | 16 | 0.0 |
Reference Values | 2 | 0.0 |
Isoenzymes/blood/*genetics | 5 | 22.0 |
Aged, 80 and over | 3 | 0.0 |
Israel | 5 | 3.0 |
Erythrocytes/*metabolism | 2 | 0.0 |
*Indians, South American | 4 | 17.0 |
Blotting, Southern | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
*Translocation, Genetic | 2 | 0.0 |
Glucose-6-Phosphate Isomerase/genetics | 3 | 27.0 |
Amino Acid Sequence | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Italy/ethnology | 2 | 5.0 |
Gene Frequency/genetics | 6 | 1.0 |
Lod Score | 5 | 0.0 |
Carboxylic Ester Hydrolases/*blood/genetics | 7 | 87.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Asian Continental Ancestry Group/*genetics | 4 | 1.0 |
Language | 2 | 8.0 |
Phosphoglucomutase/analysis | 2 | 20.0 |
Genotype | 8 | 0.0 |
Chromosome Banding | 5 | 0.0 |
Chromosomes, Human, Pair 13 | 6 | 4.0 |
DNA Probes | 3 | 0.0 |
Carboxylic Ester Hydrolases/*blood | 3 | 50.0 |
*Linkage (Genetics) | 10 | 0.0 |
Phosphogluconate Dehydrogenase/genetics | 10 | 38.0 |
Probability | 2 | 0.0 |
DNA/*genetics | 2 | 0.0 |
Hepatolenticular Degeneration/*genetics | 5 | 18.0 |
MNSs Blood-Group System/genetics | 3 | 27.0 |
Phosphoglucomutase/blood/genetics | 2 | 40.0 |
European Continental Ancestry Group/genetics | 5 | 0.0 |
Isoenzymes/*genetics | 4 | 0.0 |
Oceanic Ancestry Group/genetics | 2 | 14.0 |
Acid Phosphatase/blood | 2 | 2.0 |
Carboxylic Ester Hydrolases/blood | 2 | 22.0 |
Phosphoglucomutase/blood | 3 | 18.0 |
Linkage (Genetics) | 6 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 5 | 0.0 |
Genes, Structural | 2 | 0.0 |
Isoenzymes/*blood/genetics | 3 | 27.0 |
*Chromosome Deletion | 5 | 0.0 |
Eye Neoplasms/diagnosis/*genetics | 2 | 40.0 |
*Heterozygote Detection | 2 | 1.0 |
Retinoblastoma/diagnosis/*genetics | 2 | 20.0 |
USSR | 4 | 22.0 |
Variation (Genetics)/genetics | 2 | 1.0 |
Rh-Hr Blood-Group System/genetics | 3 | 10.0 |
Acid Phosphatase/*genetics | 4 | 10.0 |
Yugoslavia | 2 | 11.0 |
African Continental Ancestry Group/genetics | 2 | 0.0 |
South Africa | 3 | 2.0 |
Blood Grouping and Crossmatching | 4 | 5.0 |
Electrophoresis, Cellulose Acetate | 2 | 5.0 |
Evaluation Studies | 2 | 0.0 |
Isoenzymes/*analysis | 2 | 4.0 |
*Ethnic Groups | 9 | 8.0 |
Acid Phosphatase/*blood/genetics | 2 | 25.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
*Isoelectric Focusing | 3 | 12.0 |
*Alleles | 8 | 0.0 |
Karyotyping | 8 | 0.0 |
*Trisomy | 2 | 1.0 |
Genetic Markers/*blood | 3 | 75.0 |
Electrophoresis, Starch Gel | 9 | 6.0 |
Vitamin D-Binding Protein/genetics | 2 | 7.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Retinoblastoma/*genetics | 6 | 11.0 |
Superoxide Dismutase/genetics | 3 | 3.0 |
Cell Line | 3 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Greece | 2 | 2.0 |
Recombination, Genetic | 3 | 0.0 |
Sex Factors | 3 | 0.0 |
Papua New Guinea | 2 | 8.0 |
Eye Neoplasms/*diagnosis/genetics | 2 | 66.0 |
Retinoblastoma/*diagnosis/genetics | 2 | 40.0 |
Eye Neoplasms/*genetics | 4 | 17.0 |
Paternity | 2 | 2.0 |
Acid Phosphatase/blood/*genetics | 3 | 15.0 |
Esterases/blood/*genetics | 3 | 21.0 |
Enzymes/blood/*genetics | 3 | 50.0 |
Forensic Medicine/*methods | 2 | 6.0 |
Forensic Medicine | 2 | 3.0 |
*African Continental Ancestry Group | 3 | 2.0 |
Electrophoresis, Agar Gel | 3 | 0.0 |
Lyases/*genetics | 2 | 4.0 |
*Chromosomes, Human, 13-15 | 6 | 20.0 |
Genes, Dominant | 2 | 0.0 |
Chromosomes, Human, 13-15 | 2 | 25.0 |
Mutation | 3 | 0.0 |
Isoenzymes/analysis | 3 | 5.0 |
Denmark | 2 | 1.0 |
Vitamin D-Binding Protein | 2 | 7.0 |
*Immunoglobulin Allotypes | 2 | 25.0 |
Central African Republic | 2 | 28.0 |
African Continental Ancestry Group | 3 | 1.0 |
Ethnic Groups | 2 | 0.0 |
Germany, West | 4 | 8.0 |
Norway | 2 | 1.0 |
Esterases/*genetics | 2 | 2.0 |
Adenosine Deaminase/blood | 2 | 14.0 |
Adenylate Kinase/blood | 2 | 20.0 |
Esterases/blood | 2 | 16.0 |
Phosphogluconate Dehydrogenase/blood | 2 | 11.0 |
Esterases/*blood | 2 | 11.0 |
